Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01784965Phase 3Completed
A Phase 3 trial of liraglutide in prediabetes, obesity, sponsored by Stanford University. Started Dec 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01784965.